New options for the management of chronic hyperkalemia
Hyperkalemia is a frequently detected electrolyte abnormality that can cause life-threatening complications. Hyperkalemia is most often the result of intrinsic (decreased glomerular filtration rate; selective reduction in distal tubule secretory function; impaired mineralocorticoid activity; and metabolic disturbances, such as acidemia and hyperglycemia) and extrinsic factors (e.g., drugs, such as renin-angiotensin-aldosterone system inhibitors, and potassium intake). The frequent use of renin-angiotensin-aldosterone system inhibitors in patients who are already susceptible to hyperkalemia (e.g., patients with chronic kidney disease, diabetes mellitus, or congestive heart failure) contributes to the high incidence of hyperkalemia.
Source: Kidney International Supplements - Category: Urology & Nephrology Authors: Linda Fried, Csaba P. Kovesdy, Biff F. Palmer Tags: Review Source Type: research
More News: Cardiology | Chronic Kidney Disease | Congestive Heart Failure | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Failure | Potassium | Urology & Nephrology